Gregory McIntire, PhD, is Director R&D at Ameritox, Ltd. His work is focussed on improving the quality, reproducibility and speed of Urine Drug Testing and Oral Fluid Testing in the context of Pain Medication Monitoring. His group has explored hydrolysis techniques and avoiding them in the analysis of benzodiazepines and opiates. This talk will describe some efforts towards hydrolysis free analysis of benzodiazepines.